Sunshine Biopharma Inc. revenue
Sunshine Biopharma Inc.'s revenue was $36.3m in fiscal 2025, up 4.1% on the year before. Since fiscal 2019 ($21,121) it has grown at a compound 246.1% a year. Over the last twelve months it was $35.3m.
Revenue history
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 4 | 24 | 35 | 36 | 35 |
| Growth on the year before | — | — | — | +238.1% | +219.9% | +>999% | +454.4% | +44.7% | +4.1% | — |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 12 | 11 |
| Gross margin | — | — | 47.7% | 63.8% | 48.4% | 39.0% | 34.6% | 30.6% | 33.8% | 30.3% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Sunshine Biopharma Inc. | $35.3m | -2.7% | 34.5% |
| BGM Group Ltd. | $37.9m | 51.1% | — |
| IM Cannabis Corp. | $39.2m | -0.7% | — |
| Scilex Holding Co | $31.6m | -28.5% | -12.0% |
| Cumberland Pharmaceuticals Inc | $39.9m | -5.2% | -0.6% |
| Verrica Pharmaceuticals Inc. | $30.3m | 106.2% | 52.2% |
Compare with peers
- BGM Group Ltd. revenue
- IM Cannabis Corp. revenue
- Scilex Holding Co revenue
- Cumberland Pharmaceuticals Inc revenue
- Verrica Pharmaceuticals Inc. revenue
Head to head: BGM vs SBFMIMCC vs SBFMSBFM vs SCLXCPIX vs SBFM
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies